Answers are grounded in this paper and cite their sources.
Standard dosing intervals for BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines are 21 and 28 days, respectively. 1 Data suggest improved effectiveness of ChAdOx1 adenoviral 2 and other nonreplicating vaccines 3 with increased dosing intervals, but little data exist for mRNA vaccines. This study investigated the immunogenicity of extended mRNA vaccine dosing intervals.
No takes yet. Share an insight, caveat, or question.
Grunau et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: